NMRA Neumora Therapeutics, Inc.
$1.04▼ -8.77%
Healthcare
Other
After hours
$1.06▲ +1.92%
Sep 11, 7:30 PM ET
Volume 1.88M
Avg Volume (10D) 715.1K
Key Metrics & Fundamentals
Market Cap
$195.41M
P/E Ratio
–
Div Yield
–%
52W Range
0.83 - 3.65
% vs 50 MA
-32.75%
% vs 200 MA
-48.95%
RSI-14
25.6
MACD Histogram
-0.0400
Beta (1Y vs SPY)
0.77
Free Cash Flow
-$39.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$41.26M
COGS
–
Operating Exp
$42.19M
Operating Income
-$42.19M
EBIT
-$42.19M
Pretax Income
-$43.08M
Net Income
-$43.08M
EPS (Diluted)
-0.23
Price & Volume History
Loading chart…
Recent News
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
Simply Wall St. · Sep 4, 2026 10:14 PM
Neumora Therapeutics Promotes Joshua Pinto to CEO; Names New Chief Medical Officer
MT Newswires · Aug 14, 2026 12:53 PM
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 14, 2026 11:00 AM
Neumora Therapeutics Plans Q4 IND Filing for Obesity Drug After Repeat Toxicology Study
MT Newswires · Jul 27, 2026 12:21 PM
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
GlobeNewswire · Jul 27, 2026 11:00 AM
RBC Cuts Price Target on Neumora Therapeutics to $5 From $7, Keeps Outperform, Speculative Risk
MT Newswires · Jul 13, 2026 10:30 AM
Neumora Therapeutics (NMRA) Stock Sees Fair Value Falls After Navacaprant Discontinuation
Simply Wall St. · Jul 11, 2026 3:08 PM
Why Neumora Therapeutics, Inc. (NMRA) Is One of the Best Get Rich Quick Stocks to Buy
Insider Monkey · Jul 7, 2026 5:53 AM
LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 Potential
Insider Monkey · Jul 2, 2026 8:06 PM
Mizuho Adjusts Price Target on Neumora Therapeutics to $4 From $6, Maintains Outperform Rating
MT Newswires · Jun 18, 2026 12:13 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NMRA's money flow as a full page
Social Sentiment
Avg -0.10 · 4 posts
TradeDiscussionNMRA - Bull Risk Reversal
r/options · Feb 10, 2026
The author describes a 'free' bet and mentions the stock price movement, indicating a positive outlook on the company’s potential.
positive
+0.60
DiscussionDDNMRA is guaranteed money right?
r/StockMarket · Jan 6, 2025
The post expresses concern and disappointment regarding NMRA's stock drop and trial failure, indicating a negative sentiment.
negative
-0.80
DDNewsPriceTarget$NMRA: Neumora Therapeutics is about to explode
r/options · Dec 16, 2024
The post expresses optimism about NMRA's future potential due to high IV and upcoming trial results, indicating a bullish sentiment.
positive
+0.60
DDPriceTargetWhy $NMRA is going to tank 70% year end
r/wallstreetbets · Oct 21, 2024
The post predicts a significant drop in NMRA's stock price based on negative trial data and competitive pressures.
very_negative
-0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.